Report cover image

Global Encephalitis Vaccination Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 02, 2026
Length 194 Pages
SKU # APRC20822555

Description

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.

The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.

This report presents an overview of global market for Encephalitis Vaccination, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Encephalitis Vaccination, also provides the sales of main regions and countries. Of the upcoming market potential for Encephalitis Vaccination, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Encephalitis Vaccination sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Encephalitis Vaccination market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Encephalitis Vaccination sales, projected growth trends, production technology, application and end-user industry.

Encephalitis Vaccination Segment by Company

Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda

Encephalitis Vaccination Segment by Type

Encephalitis B Vaccine
Encephalitis Attenuated Live Vaccine

Encephalitis Vaccination Segment by Application

Public Hospital
Private Hospital
Clinic
Other

Encephalitis Vaccination Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encephalitis Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Encephalitis Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encephalitis Vaccination.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Encephalitis Vaccination in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Encephalitis Vaccination sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Encephalitis Vaccination Market by Type
1.2.1 Global Encephalitis Vaccination Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Encephalitis B Vaccine
1.2.3 Encephalitis Attenuated Live Vaccine
1.3 Encephalitis Vaccination Market by Application
1.3.1 Global Encephalitis Vaccination Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Public Hospital
1.3.3 Private Hospital
1.3.4 Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Encephalitis Vaccination Market Dynamics
2.1 Encephalitis Vaccination Industry Trends
2.2 Encephalitis Vaccination Industry Drivers
2.3 Encephalitis Vaccination Industry Opportunities and Challenges
2.4 Encephalitis Vaccination Industry Restraints
3 Global Market Growth Prospects
3.1 Global Encephalitis Vaccination Revenue Estimates and Forecasts (2021-2032)
3.2 Global Encephalitis Vaccination Revenue by Region
3.2.1 Global Encephalitis Vaccination Revenue by Region: 2021 VS 2025 VS 2032
3.2.2 Global Encephalitis Vaccination Revenue by Region (2021-2026)
3.2.3 Global Encephalitis Vaccination Revenue by Region (2027-2032)
3.2.4 Global Encephalitis Vaccination Revenue Market Share by Region (2021-2032)
3.3 Global Encephalitis Vaccination Sales Estimates and Forecasts 2021-2032
3.4 Global Encephalitis Vaccination Sales by Region
3.4.1 Global Encephalitis Vaccination Sales by Region: 2021 VS 2025 VS 2032
3.4.2 Global Encephalitis Vaccination Sales by Region (2021-2026)
3.4.3 Global Encephalitis Vaccination Sales by Region (2027-2032)
3.4.4 Global Encephalitis Vaccination Sales Market Share by Region (2021-2032)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Encephalitis Vaccination Revenue by Manufacturers
4.1.1 Global Encephalitis Vaccination Revenue by Manufacturers (2021-2026)
4.1.2 Global Encephalitis Vaccination Revenue Market Share by Manufacturers (2021-2026)
4.1.3 Global Encephalitis Vaccination Manufacturers Revenue Share Top 10 and Top 5 in 2025
4.2 Global Encephalitis Vaccination Sales by Manufacturers
4.2.1 Global Encephalitis Vaccination Sales by Manufacturers (2021-2026)
4.2.2 Global Encephalitis Vaccination Sales Market Share by Manufacturers (2021-2026)
4.2.3 Global Encephalitis Vaccination Manufacturers Sales Share Top 10 and Top 5 in 2025
4.3 Global Encephalitis Vaccination Sales Price by Manufacturers (2021-2026)
4.4 Global Encephalitis Vaccination Key Manufacturers Ranking, 2024 VS 2025 VS 2026
4.5 Global Encephalitis Vaccination Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Encephalitis Vaccination Manufacturers, Product Type & Application
4.7 Global Encephalitis Vaccination Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Encephalitis Vaccination Market CR5 and HHI
4.8.2 2025 Encephalitis Vaccination Tier 1, Tier 2, and Tier 3
5 Encephalitis Vaccination Market by Type
5.1 Global Encephalitis Vaccination Revenue by Type
5.1.1 Global Encephalitis Vaccination Revenue by Type (2021 VS 2025 VS 2032)
5.1.2 Global Encephalitis Vaccination Revenue by Type (2021-2032) & (US$ Million)
5.1.3 Global Encephalitis Vaccination Revenue Market Share by Type (2021-2032)
5.2 Global Encephalitis Vaccination Sales by Type
5.2.1 Global Encephalitis Vaccination Sales by Type (2021 VS 2025 VS 2032)
5.2.2 Global Encephalitis Vaccination Sales by Type (2021-2032) & (10K Person-time)
5.2.3 Global Encephalitis Vaccination Sales Market Share by Type (2021-2032)
5.3 Global Encephalitis Vaccination Price by Type
6 Encephalitis Vaccination Market by Application
6.1 Global Encephalitis Vaccination Revenue by Application
6.1.1 Global Encephalitis Vaccination Revenue by Application (2021 VS 2025 VS 2032)
6.1.2 Global Encephalitis Vaccination Revenue by Application (2021-2032) & (US$ Million)
6.1.3 Global Encephalitis Vaccination Revenue Market Share by Application (2021-2032)
6.2 Global Encephalitis Vaccination Sales by Application
6.2.1 Global Encephalitis Vaccination Sales by Application (2021 VS 2025 VS 2032)
6.2.2 Global Encephalitis Vaccination Sales by Application (2021-2032) & (10K Person-time)
6.2.3 Global Encephalitis Vaccination Sales Market Share by Application (2021-2032)
6.3 Global Encephalitis Vaccination Price by Application
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Business Overview
7.1.3 Novartis Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.1.4 Novartis Encephalitis Vaccination Product Portfolio
7.1.5 Novartis Recent Developments
7.2 Sanofi
7.2.1 Sanofi Company Information
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.2.4 Sanofi Encephalitis Vaccination Product Portfolio
7.2.5 Sanofi Recent Developments
7.3 Chengdu Institute of Biological Products
7.3.1 Chengdu Institute of Biological Products Company Information
7.3.2 Chengdu Institute of Biological Products Business Overview
7.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.3.4 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolio
7.3.5 Chengdu Institute of Biological Products Recent Developments
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Company Information
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.4.4 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolio
7.4.5 Wuhan Institute of Biological Products Recent Developments
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Company Information
7.5.2 Lanzhou Institute of Biological Products Business Overview
7.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolio
7.5.5 Lanzhou Institute of Biological Products Recent Developments
7.6 Beijing Taitan
7.6.1 Beijing Taitan Company Information
7.6.2 Beijing Taitan Business Overview
7.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.6.4 Beijing Taitan Encephalitis Vaccination Product Portfolio
7.6.5 Beijing Taitan Recent Developments
7.7 Valneva
7.7.1 Valneva Company Information
7.7.2 Valneva Business Overview
7.7.3 Valneva Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.7.4 Valneva Encephalitis Vaccination Product Portfolio
7.7.5 Valneva Recent Developments
7.8 Bharat Biotech
7.8.1 Bharat Biotech Company Information
7.8.2 Bharat Biotech Business Overview
7.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.8.4 Bharat Biotech Encephalitis Vaccination Product Portfolio
7.8.5 Bharat Biotech Recent Developments
7.9 Liaoning Chengda
7.9.1 Liaoning Chengda Company Information
7.9.2 Liaoning Chengda Business Overview
7.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
7.9.4 Liaoning Chengda Encephalitis Vaccination Product Portfolio
7.9.5 Liaoning Chengda Recent Developments
8 North America
8.1 North America Encephalitis Vaccination Market Size by Type
8.1.1 North America Encephalitis Vaccination Revenue by Type (2021-2032)
8.1.2 North America Encephalitis Vaccination Sales by Type (2021-2032)
8.1.3 North America Encephalitis Vaccination Price by Type (2021-2032)
8.2 North America Encephalitis Vaccination Market Size by Application
8.2.1 North America Encephalitis Vaccination Revenue by Application (2021-2032)
8.2.2 North America Encephalitis Vaccination Sales by Application (2021-2032)
8.2.3 North America Encephalitis Vaccination Price by Application (2021-2032)
8.3 North America Encephalitis Vaccination Market Size by Country
8.3.1 North America Encephalitis Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
8.3.2 North America Encephalitis Vaccination Sales by Country (2021 VS 2025 VS 2032)
8.3.3 North America Encephalitis Vaccination Price by Country (2021-2032)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Encephalitis Vaccination Market Size by Type
9.1.1 Europe Encephalitis Vaccination Revenue by Type (2021-2032)
9.1.2 Europe Encephalitis Vaccination Sales by Type (2021-2032)
9.1.3 Europe Encephalitis Vaccination Price by Type (2021-2032)
9.2 Europe Encephalitis Vaccination Market Size by Application
9.2.1 Europe Encephalitis Vaccination Revenue by Application (2021-2032)
9.2.2 Europe Encephalitis Vaccination Sales by Application (2021-2032)
9.2.3 Europe Encephalitis Vaccination Price by Application (2021-2032)
9.3 Europe Encephalitis Vaccination Market Size by Country
9.3.1 Europe Encephalitis Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
9.3.2 Europe Encephalitis Vaccination Sales by Country (2021 VS 2025 VS 2032)
9.3.3 Europe Encephalitis Vaccination Price by Country (2021-2032)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Encephalitis Vaccination Market Size by Type
10.1.1 China Encephalitis Vaccination Revenue by Type (2021-2032)
10.1.2 China Encephalitis Vaccination Sales by Type (2021-2032)
10.1.3 China Encephalitis Vaccination Price by Type (2021-2032)
10.2 China Encephalitis Vaccination Market Size by Application
10.2.1 China Encephalitis Vaccination Revenue by Application (2021-2032)
10.2.2 China Encephalitis Vaccination Sales by Application (2021-2032)
10.2.3 China Encephalitis Vaccination Price by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Encephalitis Vaccination Market Size by Type
11.1.1 Asia Encephalitis Vaccination Revenue by Type (2021-2032)
11.1.2 Asia Encephalitis Vaccination Sales by Type (2021-2032)
11.1.3 Asia Encephalitis Vaccination Price by Type (2021-2032)
11.2 Asia Encephalitis Vaccination Market Size by Application
11.2.1 Asia Encephalitis Vaccination Revenue by Application (2021-2032)
11.2.2 Asia Encephalitis Vaccination Sales by Application (2021-2032)
11.2.3 Asia Encephalitis Vaccination Price by Application (2021-2032)
11.3 Asia Encephalitis Vaccination Market Size by Country
11.3.1 Asia Encephalitis Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
11.3.2 Asia Encephalitis Vaccination Sales by Country (2021 VS 2025 VS 2032)
11.3.3 Asia Encephalitis Vaccination Price by Country (2021-2032)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Encephalitis Vaccination Market Size by Type
12.1.1 SAMEA Encephalitis Vaccination Revenue by Type (2021-2032)
12.1.2 SAMEA Encephalitis Vaccination Sales by Type (2021-2032)
12.1.3 SAMEA Encephalitis Vaccination Price by Type (2021-2032)
12.2 SAMEA Encephalitis Vaccination Market Size by Application
12.2.1 SAMEA Encephalitis Vaccination Revenue by Application (2021-2032)
12.2.2 SAMEA Encephalitis Vaccination Sales by Application (2021-2032)
12.2.3 SAMEA Encephalitis Vaccination Price by Application (2021-2032)
12.3 SAMEA Encephalitis Vaccination Market Size by Country
12.3.1 SAMEA Encephalitis Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
12.3.2 SAMEA Encephalitis Vaccination Sales by Country (2021 VS 2025 VS 2032)
12.3.3 SAMEA Encephalitis Vaccination Price by Country (2021-2032)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Encephalitis Vaccination Value Chain Analysis
13.1.1 Encephalitis Vaccination Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Encephalitis Vaccination Production Mode & Process
13.2 Encephalitis Vaccination Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Encephalitis Vaccination Distributors
13.2.3 Encephalitis Vaccination Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.